Buscar
Mostrando ítems 1-10 de 16
Is SARS-CoV-2 the only cause of long-COVID?
Around 10% of adults infected with SARS-CoV-2 that survive a first episode of COVID-19 appear to experience long-term clinical manifestations. The signs and symptoms of this post-acute COVID-19 syndrome (PACS) include ...
Clinical Heterogeneity in ME/CFS: A Way to Understand Long-COVID19 Fatigue
(Frontiers Media, 2021-10)
The aim of present paper is to identify clinical phenotypes in a cohort of patients affected of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ninety-one patients and 22 healthy controls were studied with the following ...
Os efeitos do exercício físico na fadiga mental pós-viral da Covid-19: um estudo piloto
(2021)
INTRODUÇÃO: A Covid-19 é descrita atualmente como a maior pandemia de Coronavírus da história. Para além do número de óbitos alarmante, aqueles sobreviveram à infecção estão apresentando frequentemente sequelas físicas, ...
Síndrome de fatiga crónica: Una aproximación a su comprensión desde la psicología y el trabajo interdisciplinario
(Universidad de La SabanaPsicologíaFacultad de Psicología, 2012-12-10)
El objetivo del trabajo, fue realizar una revisión desde la perspectiva psicológica y aportes al trabajo interdisciplinario en el Síndrome de Fatiga Crónica, cuyo fin es brindar alternativas conceptuales que faciliten su ...
Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution
(Mdpi, 2022-08-01)
The intestinal microbiota plays an important role in the immune response against viral infections, modulating both innate and adaptive immune responses. The cytokine storm is associated with COVID-19 severity, and the ...
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Background A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and
immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the ...
Long-term (6 months) neurological and psychiatric consequences in mild COVID community patients
(Corporación Universidad de la CostaColombia, 2022)
Consecuencias neurológicas y psiquiátricas a largo plazo (6 meses) en pacientes con COVID leve de la comunidadLong-term (6 months) neurological and psychiatric consequences in mild COVID community patients
(Corporación Universidad de la CostaColombia, 2023)
Characterization and investigation of risk factors for Late-relapsing hepatitis after yellow fever
(Oxford University Press, 2023)